NPHP5 gene therapy(National Eye Institute)

N/A

Report date: 2024/10/28 14:36:16

Base Information

Drug NameNPHP5 gene therapy(National Eye Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionNPHP5 protein modulators
TargetsNPHP5 protein
Therapy Area/IndicationsLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Eye Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Eye Institute
Inactive CompaniesN/A
Active IndicationsLeber Congenital Amaurosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A